The Every Newborn Action Plan (ENAP) launched on June 30–July 1, 2014, envisages a world without preventable deaths of newborn infants. The challenge is not technical (effective interventions exist), but instead social. The odds of a child surviving the first month of life are grossly unequal, even within one country, and are affected by wealth, education, caste, and access to health care. Large gains are achievable when interventions reach people who are in need, but this rarely occurs. Without dedicated efforts to reach poor people, ENAP initiatives are likely to favour wealthier people who have the lowest mortality risk.
Although Millennium Development Goals 4, 5, and 6 have helped mobilise global action to improve health, many sub-Saharan African countries will not come close to Read More
New Article in JAMA by Smisha Agarwal, MPH, MBA, BDS and Alain Labrique, PhD, MHS, MS. JAMA Network | JAMA | Newborn Health on the Line: The Potential mHealth Applications.
Imagine providing care for 900 000 low birthweight (LBW; lighter than 2500 g) newborn babies each year in sub-Saharan Africa—all attributable to preventable and treatable malaria. Many of these LBW babies will be born in rural and impoverished settings where access to health care is poorest and the risk of complicating factors, including other infectious diseases and undernutrition, is most pronounced. This scenario, with the caveat that no malaria prevention services are provided, is the sobering estimate of malaria-attributable LBW for 2010 provided by Patrick Walker and colleagues in this issue of The Lancet Global Health.
Babies and children feature heavily in this August issue of The Lancet Global Health, as well they should at a time when unfinished agendas are top of the agenda. In its 2014 report on the Millennium Development Goals, released on July 7, the UN described the under-5 mortality goal as “slipping away from achievement by 2015”. The research and opinion in this month’s issue harnesses a variety of different angles from which to “move the needle” on neonatal and child health. How can we ensure that neonatal interventions reach the very poorest families who need them the most? Are we doing enough for children with tuberculosis
Critical Public Health, Ahead of Print.
by Aurélien Fotso Fotso, Oleg Mediannikov, Georges Diatta, Lionel Almeras, Christophe Flaudrops, Philippe Parola, Michel Drancourt Background In Africa, relapsing fever borreliae are neglected vector-borne pathogens that cause mild to deadly septicemia and miscarriage. Screening vectors for the presence of borreliae currently requires technically demanding, time- and resource-consuming molecular methods. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) has recently emerged as a tool for the rapid identification of vectors and the identification of cultured borreliae
by Megan E. Reller, Elsio A.
by Sachiyo Nagi, Evans A. Chadeka, Toshihiko Sunahara, Faith Mutungi, Yombo K. Dan Justin, Satoshi Kaneko, Yoshio Ichinose, Sohkichi Matsumoto, Sammy M
by James Weger-Lucarelli, Haiyan Chu, Matthew T. Aliota, Charalambos D.
by Donal Bisanzio, Francis Mutuku, Amaya L. Bustinduy, Peter L.
by Natsuko Imai, Michael T. White, Azra C. Ghani, Chris J.
by Moataz Abd El Ghany, Jagadish Chander, Ankur Mutreja, Mamoon Rashid, Grant A. Hill-Cawthorne, Shahjahan Ali, Raeece Naeem, Nicholas R.
by Vinícius Silva Belo, Claudio José Struchiner, David Soeiro Barbosa, Bruno Warlley Leandro Nascimento, Marco Aurélio Pereira Horta, Eduardo Sérgio da Silva, Guilherme Loureiro Werneck Background In the current context of high fatality rates associated with American visceral leishmaniasis (VL), the appropriate use of prognostic factors to identify patients at higher risk of unfavorable outcomes represents a potential tool for clinical practice. This systematic review brings together information reported in studies conducted in Latin America, on the potential predictors of adverse prognosis (continued evolution of the initial clinical conditions of the patient despite the implementation of treatment, independent of the occurrence of death) and death from VL. The limitations of the existing knowledge, the advances achieved and the approaches to be used in future research are presented
by Peter J. Hotez, Miriam Alvarado, María-Gloria Basáñez, Ian Bolliger, Rupert Bourne, Michel Boussinesq, Simon J.
One of the most dramatic international responses to the Millennium Development Goals launched by then United Nations Secretary Kofi Annan in 2000 has been the global public health community’s response to MDG 6 “To combat AIDS, malaria and other diseases” . …The post Millennium Development Goal 6: Measuring Progress appeared first on Speaking of Medicine.
Objective: This paper examines the scope of practice of global health, drawing on the practical experience of a global health initiative of the Government of Canada – the Teasdale-Corti Global Health Research Partnership Program.